Cyclopharm Limited (Premium)



Ticker code: ASX:CYG

ASX:CYG Red Flags & Risk Indicators
⚠️
⚠️ RED FLAGS: 2 identified

  • Falling Earnings
  • More Net Debt Than Equity

Income Statement
Revenue 2024 Per Share Revenue 2025e Per Share Revenue 2026e Per Share Revenue 24 to 25e [%] Revenue 25e to 26e [%] EBITDA 2024 Per Share EBITDA 2025e Per Share EBITDA 2026e Per Share EBITDA 24 to 25e [%] EBITDA 25e to 26e [%]
3.1747 None None None None 0.17808 0.18107 None 1.7 None
ASX:CYG Revenue Per Share (2012–2027)

Cyclopharm Limited (ASX:CYG) Revenue Chart 2012–2027
ASX:CYG Earnings before Interest, Tax, Depreciation and Amortisation (EBITDA) Per Share (2012–2027)
Cyclopharm Limited (ASX:CYG) EBITDA Chart 2012–2027
ASX:CYG Normalised Earnings Per Share (EPS) (2012–2027)
✅✅
Cyclopharm Limited (ASX:CYG) Normalised EPS Chart (2012–2027)

Valuation
Price To Sales Price To Book PER 2023 PER 2024 13Y Median PER Low PER 2025e 13Y Median PER High PER 2026e Last Updated
0.2 0.8 None 7.8 9.1 5.8 16.0 4.7 19/7/22
ASX:CYG Yearly Price Earnings Ratio (PER) Highs and Lows
✅✅
Cyclopharm Limited (ASX:CYG) PER Highs and Lows (2012–2027)
ASX:CYG Weekly Price Chart with Average True Range (ATR) Trailing Stop (10-Year View)
Cyclopharm Limited (ASX:CYG) 10-Year Weekly ATR Trailing Stop Price Chart


Leave a Reply

Your email address will not be published. Required fields are marked *